Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1 1

Status

Completed 45Terminated 6Recruiting 6Withdrawn 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 142INDUSTRY 64NIH 7NETWORK 6OTHER_GOV 3UNKNOWN 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 6

Conditions

Breast Neoplasms 18Prostatic Neoplasms 15Neoplasms 12Multiple Myeloma 11Carcinoma, Non-Small-Cell Lung 11Melanoma 9Pancreatic Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lung Neoplasms 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Sarcoma 4Ovarian Neoplasms 4Osteosarcoma 4Hematologic Neoplasms 4Brain Neoplasms 4Teratoma 3Smoldering Multiple Myeloma 3Small Cell Lung Carcinoma 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Neoplasm Metastasis 3Malignant Solid Neoplasm 3HIV Infections 3Fallopian Tube Neoplasms 3Colonic Neoplasms 3

Interventions

fludarabine 2axicabtagene ciloleucel 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2zanubrutinib 1tisagenlecleucel 1tazemetostat 1tafasitamab 1spartalizumab 1polatuzumab vedotin 1Watchful Waiting 1Observation 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Lenalidomide 1Immunoglobulins 1Drug Therapy 1Disulfides 1CTL019 chimeric antigen receptor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Lymphoma, Large B-Cell, Diffuse × Clear all
NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

SWOG Cancer Research Network

Phase 2 Recruiting
396 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05890352 2025-10-20

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

SWOG Cancer Research Network

Phase 2 Recruiting
227 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06764017 2025-03-19

CHiR Therapy for Elderly DLBCL Intolerant to Chemo

First Affiliated Hospital of Ningbo University

Phase 2 Recruiting
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06758037 2025-03-18

HiR+X

First Affiliated Hospital of Ningbo University

Phase 2 Recruiting
50 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04332822 2024-09-19

POLAR BEAR

Nordic Lymphoma Group

Phase 3 Recruiting
300 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡